FDA RECALL Brand: Rising Pharma Holdings Inc. Product: Cetirizine Hydrochloride Tablets USP 5 mg Issue: Potential cross contamination with Ranitidine Date: 07/20/2026 More: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/unique-pharmaceutical-laboratories-div-j-b-chemicals-pharmaceuticals-ltd-issues-voluntary-nationwide #FDA #recall